Short answer
Quest Diagnostics (DGX) filed its Q3 2026 10-Q quarterly report on Oct 23, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $3.1B (up 10.0% year over year) with net income of $312M.
Q3 2026 key financials · XBRL
- Revenue
- $3.1B
- +10.0% YoY · +1.8% QoQ
- Net income
- $312M
- +27.3% YoY · −2.5% QoQ
- Operating margin
- 15.5%
- EPS (diluted)
- $2.78
- +28.7% YoY · −2.1% QoQ
Source: XBRL data from the Quest Diagnostics (DGX) Q3 2026 10-Q on SEC EDGAR. USD.
Quest Diagnostics Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $3,097M, up 10.0% YoY from $2,816M, driven by DIS revenue growth of 10.2%
- Operating margin 15.5% vs 13.7% YoY, net income $312M vs $245M
- Best performer DIS: $3,035M revenue, up 10.2%; DS revenue $62M vs $61M
- Operating cash flow $611M vs $563M; capital expenditures $166M vs $144M
- Cash $797M vs $420M at December 31, 2025; reimbursement pressures and higher compensation costs remained headwinds
Risk Factors
- No material changes to risk factors reported from December 31, 2025 Form 10-K
- Carried-forward risks remain governed by the 2025 Annual Report’s risk-factor disclosures
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Quest Diagnostics quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.